| Jessica D Allen, | |
|
420 Kellogg Ave, Ames, IA 50010-6226 | |
| (515) 233-2250 | |
| Not Available |
| Full Name | Jessica D Allen |
|---|---|
| Gender | Female |
| Speciality | Counselor |
| Location | 420 Kellogg Ave, Ames, Iowa |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215198528 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jessica D Allen, 420 Kellogg Ave, Ames, IA 50010-6226 Ph: (515) 233-2250 | Jessica D Allen, 420 Kellogg Ave, Ames, IA 50010-6226 Ph: (515) 233-2250 |
News Archive
CAHG, a leading professional healthcare communications agency, was named the winner of the Med Ad News Vision Award at last night's 22nd Annual Manny Awards at the Sheraton New York Hotel and Towers in New York.
Scientists at The New York Stem Cell Foundation (NYSCF) Research Institute, working in collaboration with scientists from Columbia University Medical Center (CUMC), for the first time generated induced pluripotent stem (iPS) cells lines from non-cryoprotected brain tissue of patients with Alzheimer's disease.
Inovio Pharmaceuticals, Inc. announced today it has received a U.S. Department of Defense Small Business Innovation Research Grant to advance the development of a low-cost, non-invasive surface electroporation (EP) delivery device and test its utility in combination with Inovio's novel synthetic DNA vaccines against viruses with bioterrorism potential, including hanta, puumala, arenavirus and pandemic influenza.
Drug discovery company SCYNEXIS, Inc. today presented data supporting an impressive resistance profile for SCY-635—a novel, oral cyclophilin inhibitor being studied for the treatment of hepatitis C virus (HCV) infection. In the study, SCYNEXIS demonstrated that the hepatitis C virus required multiple mutations across two separate proteins in order to establish resistance to SCY-635. The majority of HCV drugs on the market and in development require only one targeted viral mutation to establish resistance.
In anticipation of the release of the Institute of Medicine (IOM) report on viral hepatitis, the CDC Foundation (the independent nonprofit partner of the Centers for Disease Control and Prevention), in partnership with CDC's Division of Viral Hepatitis, recently launched the Viral Hepatitis Action Coalition.
› Verified 4 days ago
Valerie Stubbs, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1525 Airport Rd Ste 100, Ames, IA 50010 Phone: 511-292-3023 | |
Christa Jean Reynolds, LMSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 420 Kellogg Ave, Ames, IA 50010 Phone: 515-233-2250 Fax: 515-233-3235 | |
Sarah Statz, TLMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 223 S Walnut Ave, Ames, IA 50010 Phone: 515-368-7504 Fax: 515-355-3491 | |
Meredith Francom, TLMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 614 Billy Sunday Rd Ste 100, Ames, IA 50010 Phone: 515-337-1764 Fax: 515-337-0480 | |
Dr. Jill Jordahl-ball, PSYD Counselor Medicare: Not Enrolled in Medicare Practice Location: 3510 Lincoln Way Ste 300, Ames, IA 50014 Phone: 515-292-9251 Fax: 844-895-6179 | |
Kathleen Mcomber Lind, Counselor Medicare: Not Enrolled in Medicare Practice Location: 420 Kellogg Ave, Ames, IA 50010 Phone: 515-233-2250 Fax: 515-233-2440 | |
Shaquille Grant Jr., Counselor Medicare: Not Enrolled in Medicare Practice Location: 804 Kellogg Ave, Ames, IA 50010 Phone: 515-233-4931 |